about
Advanced glycation end products and diabetic complicationsStore-operated calcium entry and diabetic complicationsEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsPimagedine: a novel therapy for diabetic nephropathy.Medical management of diabetic retinopathy.Cutaneous microvascular dysfunction is associated with human leukocyte antigen-DQ in youths with type 1 diabetes.Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells.Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucoseAdvanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.Early utilization of hypertonic peritoneal dialysate and subsequent risks of non-traumatic amputation among peritoneal dialysis patients: a nationwide retrospective longitudinal study.The renin-angiotensin-aldosterone system and the eye in diabetes.Selective down-regulation of KV2.1 function contributes to enhanced arterial tone during diabetesReversal of diabetic vasculopathy in a rat model of type 1 diabetes by opiorphin-related peptidesCanonical transient receptor potential channels in diabetes.Disrupted Nitric Oxide Metabolism from Type II Diabetes and Acute Exposure to Particulate Air Pollution.Changes in retinal microvascular diameter in patients with diabetesCytokines and vascular reactivity in resistance arteries.Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitusDiabetes-associated macrovasculopathy: pathophysiology and pathogenesis.Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats.The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.Protective effects of physiological testosterone on advanced glycation end product‑induced injury in human endothelial cells.Endoplasmic-reticulum calcium depletion and disease.Advanced glycation end products and diabetic retinopathy.The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.Of mice and mutations: phenotypic effects of the diabetic db/db and ob/ob mutations on the skull and teeth of mice.Prevention of protein glycation by natural compounds.Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?Rheumatic fever pathogenesis: Approach in research needs change.Inhibition of Porcine Pancreatic Amylase Activity by Sulfamethoxazole: Structural and Functional Aspect.Arsenic-induced decreases in the vascular matrix.MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.Post-bronchoscopy fatal endobronchial hemorrhage in a woman with bronchopulmonary mucormycosis: a case report.Contribution of nitric oxide produced by inducible nitric oxide synthase to vascular responses of mesenteric arterioles in streptozotocin-diabetic rats.
P2860
Q27687501-1E3395B4-5927-4E2C-8E29-82F25B5A3A24Q28085037-3FBA017A-1B6F-4A66-A9B5-7521B41F4778Q28730724-54F12116-4294-4911-9391-01D2990F0D7DQ30309168-4D8934E9-95B7-4789-A460-18F0064E4672Q33204062-0157BC3E-A943-4C11-817C-8358D542DD81Q33324823-33241D28-E459-4F11-A8A4-3232E9462D6CQ33654306-8068D7D1-5DAF-4470-8C49-B2BB38777E76Q33655566-56AA4E81-614C-4A55-A749-D299685F4279Q33726224-1544FE81-6BDE-4590-9EB6-9B533376E726Q34448452-1A24A8F0-804B-4CD4-90BC-B94DEAACE54CQ34623238-E092DE92-A07F-4E12-A77E-177E5DBC82F2Q34779363-A06A3BB8-91D8-4D52-A315-DEE6804E2F3FQ35065528-C625D177-999B-4B58-A87B-5A670F8D0216Q35199477-444C8321-ADA5-47FC-80A4-DF3183C1CB62Q35395573-C67F571E-DBDD-40CB-A8B2-4EABD033E67CQ35838500-418354F1-56FE-4137-B18B-E94F185A5CA3Q35866156-BD230696-B9F1-4287-8EC8-28B50A0C5888Q36010448-FF85550C-1B6D-425C-8493-720DC2387C8BQ36038059-93F4124B-445C-419C-A4B1-AD951BA317D7Q36204031-C117809D-0FF7-4BCA-8700-2D650EEB46B8Q36587512-D77B615A-683F-483B-8630-CAAA201A54E4Q36966060-651E28D9-16C1-40C7-8603-2F7501A91A0DQ37106691-9A4FEDF8-A655-4C0C-8DD2-A5176F482F7BQ37262676-ACF30D8C-3A64-4763-AFCC-B7BBACA6ECB7Q37611981-EA422400-38F2-43D6-9979-2971CD5C93DAQ37631275-DA2A50E7-740B-4C6A-BCCC-6012EE19F032Q37722123-7A5A1AF7-36EB-4639-994C-BD59CD419BDBQ37858336-9CC97686-FC9E-4FA3-B54F-451D238DED21Q38193463-A0E19AE1-C7E8-4040-807B-87859D8E6522Q38200957-5B4261FB-3EDF-4590-A7F0-966C12DD0446Q38292864-47020677-465C-40B4-8E8F-3977514D54D7Q38358965-A1CFA659-9854-4B3C-8976-69FDF40F29F7Q39451162-22F3ED2D-575E-41CD-B9C5-A3C21FC23FACQ40269065-87F04C36-68FD-47B3-AFB8-5157E025C1D0Q40641903-C77EB359-6706-4416-A690-C5EC37E36D9FQ40734329-D6D35CCE-44E7-4D4B-B903-08B0AB45D84EQ41099760-D2254FDD-673F-4C49-902F-DCB709ED61C6Q41434069-754B2C41-62CB-4535-8931-E6CBA2F47D45Q41611366-0CD01803-228F-4CFA-AD05-F5300099B074Q41824174-323BB06B-14F9-42B0-98ED-B6402077EF5B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Mechanisms of diabetic vasculopathy: an overview.
@ast
Mechanisms of diabetic vasculopathy: an overview.
@en
Mechanisms of diabetic vasculopathy: an overview.
@nl
type
label
Mechanisms of diabetic vasculopathy: an overview.
@ast
Mechanisms of diabetic vasculopathy: an overview.
@en
Mechanisms of diabetic vasculopathy: an overview.
@nl
prefLabel
Mechanisms of diabetic vasculopathy: an overview.
@ast
Mechanisms of diabetic vasculopathy: an overview.
@en
Mechanisms of diabetic vasculopathy: an overview.
@nl
P2093
P1476
Mechanisms of diabetic vasculopathy: an overview
@en
P2093
K Jandeleit-Dahm
M E Cooper
M Oldfield
P304
P356
10.1016/S0895-7061(00)01323-6
P433
P577
2001-05-01T00:00:00Z